Mesa Laboratories Inc 最大收入来源是 Sterilization and Disinfection Control,在最近的收益报告中收入为 75,124,000。就地区而言, United States 是 Mesa Laboratories Inc 的主要市场,收入为 106,395,000。
Mesa Laboratories Inc 是否盈利?
不,根据最新的财务报表,Mesa Laboratories Inc 的净损失为 $-1
Mesa Laboratories Inc 有负债吗?
是的,Mesa Laboratories Inc 的负债为 273
Mesa Laboratories Inc 的流通股有多少?
Mesa Laboratories Inc 的总流通股为 5.45
关键数据
前收盘价
$88.46
开盘价
$87.25
当日区间
$86.51 - $91.27
52周范围
$55.45 - $131.2
交易量
90.7K
平均成交量
109.6K
股息收益率
0.68%
每股收益(TTM)
0.65
市值
$502.7M
什么是 MLAB?
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. The company is headquartered in Lakewood, Colorado and currently employs 730 full-time employees. The firm's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.